Cited by 330Reproductive tract infections researchCervical Cancer and HPV ResearchHIV/AIDS Research and Interventions

Extragenital Infections Caused by Chlamydia trachomatis and Neisseria gonorrhoeae: A Review of the Literature

Open access
Chan, Philip A., Robinette, Ashley, Montgomery, Madeline, Almonte, Alexi, Cu-Uvin, Susan, Lonks, John R., Chapin, Kimberle C., Kojic, Erna M. +1 more·2016·Infectious Diseases in Obstetrics and Gynecology

Abstract

In the United States, sexually transmitted diseases due to Chlamydia trachomatis and Neisseria gonorrhoeae continue to be a major public health burden. Screening of extragenital sites including the oropharynx and rectum is an emerging practice based on recent studies highlighting the prevalence of infection at these sites. We reviewed studies reporting the prevalence of extragenital infections in women, men who have sex with men (MSM), and men who have sex only with women (MSW), including distribution by anatomical site. Among women, prevalence was found to be 0.6-35.8% for rectal gonorrhea (median reported prevalence 1.9%), 0-29.6% for pharyngeal gonorrhea (median 2.1%), 2.0-77.3% for rectal chlamydia (median 8.7%), and 0.2-3.2% for pharyngeal chlamydia (median 1.7%). Among MSM, prevalence was found to be 0.2-24.0% for rectal gonorrhea (median 5.9%), 0.5-16.5% for pharyngeal gonorrhea (median 4.6%), 2.1-23.0% for rectal chlamydia (median 8.9%), and 0-3.6% for pharyngeal chlamydia (median 1.7%). Among MSW, the prevalence was found to be 0-5.7% for rectal gonorrhea (median 3.4%), 0.4-15.5% for pharyngeal gonorrhea (median 2.2%), 0-11.8% for rectal chlamydia (median 7.7%), and 0-22.0% for pharyngeal chlamydia (median 1.6%). Extragenital infections are often asymptomatic and found in the absence of reported risk behaviors, such as receptive anal and oral intercourse. We discuss current clinical recommendations and future directions for research.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2016/5758387

Cites

171 of 171 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Basing screening practices solely on history might be suboptimal because providers might feel uncomfortable taking a detailed sexual history, men might also feel uncomfortable sharing personal sexual information with their provider, and rectal and pharyngeal infections can be identified even in the absence of reported risk behaviors.

    “Basing screening practices solely on history might be suboptimal because providers might feel uncomfortable taking a detailed sexual history (229), men might also feel uncomfortable sharing personal sexual information with their provider, and rectal and pharyngeal infections can be identified even in the absence of reported risk behaviors (171).”

    From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [171]

    Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured
  • Among MSM, prevalence of rectal gonorrhea and chlamydia ranges from 0.2% to 24% and 2.1% to 23%, respectively, and prevalence of pharyngeal gonorrhea and chlamydia ranges from 0.5% to 16.5% and 0% to 3.6%, respectively.

    “Studies have demonstrated that among MSM, prevalence of rectal gonorrhea and chlamydia ranges from 0.2% to 24% and 2.1% to 23%, respectively, and prevalence of pharyngeal gonorrhea and chlamydia ranges from 0.5% to 16.5% and 0% to 3.6%, respectively (171).”

    From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [171]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. [22]Koedijk F. D. H. van Bergen J. E. A. M. Dukers-Muijrers N. H. T. M. van Leeuwen A. P. Hoebe C. J. P. A. van der Sande M. A. B. The value of testing multiple anatomic sites for gonorrhoea and chlamydia in sexually transmitted infection centres in the Netherlands, 2006–2010 International Journal of STD & AIDS 2012 23 9 626 631 10.1258/ijsa.2012.011378 2-s2.0-84867067962 23033514 · DOI · Paper page
  2. [53]Barry P. M. Kent C. K. Philip S. S. Klausner J. D. Results of a program to test women for rectal chlamydia and gonorrhea Obstetrics & Gynecology 2010 115 4 753 759 10.1097/aog.0b013e3181d444f6 2-s2.0-77949910818 20308835 · DOI
  3. [151]Chen M. Y. Stevens K. Tideman R. Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia The Journal of Antimicrobial Chemotherapy 2013 68 6 1445 1447 10.1093/jac/dkt017 2-s2.0-84891462477 23390207 · DOI

Cited by

Sorted by citations

Authors
Chan, P. A., Robinette, A., Montgomery, M., Almonte, A., Cu-Uvin, S., Lonks, J. R., Chapin, K. C., Kojic, E. M., & Hardy, E. J.
Affiliations
  • Brown University (US)
  • Division of Infectious Diseases, Department of Medicine, Warren Alpert Medical School, Brown University, Providence, RI 02903, USA
  • Rhode Island Hospital (US)
Corresponding author
Chan, Philip A.
Venue
Infectious Diseases in Obstetrics and Gynecology
Publisher
Wiley
Published
2016
Volume
2016
Pages
1-17
ISSN
  • 1064-7449 (ISSN-L)
  • 1098-0997
OpenAlex
W2413108535
Cited by
330
References
171
Citations by year
2026: 19 · 2025: 17 · 2024: 44 · 2023: 35 · 2022: 39 · 2021: 58 · 2020: 42 · 2019: 33 · 2018: 27 · 2017: 15
FWCI
2.76
Type
journal article
Language
en
Open access
Locations
  • Infectious Diseases in Obstetrics and Gynecology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institutes of Health (K23AI096923, P30AI042853)
  • National Institute of Allergy and Infectious Diseases (K23AI096923, P30AI042853)
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
  • Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Keywords
Chlamydia trachomatis, Neisseria gonorrhoeae, extragenital infection, rectal gonorrhea, pharyngeal gonorrhea, rectal chlamydia, sexually transmitted infections, prevalence, men who have sex with men, women, asymptomatic infection, screening
MeSH terms
Chlamydia Infections, Chlamydia trachomatis, Female, Gonorrhea, Humans, Male, Neisseria gonorrhoeae, Sexual Behavior

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review